Evaluation of the Effectiveness of the TOVERTAFEL System on Behavioral Disorders

Phase

N/A

Condition

Attention Deficit/hyperactivity Disorder (Adhd - Pediatric)

Oppositional Defiant Disorder (Odd)

Treatment

N/A

Clinical Study ID

NCT04421833

69HCL20_0145

Ages 60-106
All Genders

Study Summary

The prevalence of behavioral disorders is high in patients living in an institutional environment or hospitalized in a long-term care unit. The consequences of these symptoms are not negligible with a faster cognitive decline and a significant impact on the life of the institution and of other patients when the disorders are pervasive and too difficult to manage for the healthcare teams.

Despite the daily attention paid to these disorders and their causes, especially the environmental ones, the teams are sometimes helpless, the teams are sometimes helpless today to fight against these symptoms, and their management thus constitutes a real challenge.

Non-drug interventions targeting this problem often require additional training, architectural installations (Snoezelen space) and / or are moderately effective. In order to offer a solution that can be used by everyone, that is transportable and based on new technologies, the TOVERTAFEL device was created.

These are interactive games projected onto a table using a ceiling projector. The light animations invite people to "play with the light" using arm or hand movements. These games stimulate residents' physical activity and encourage interactions between residents and with caregivers.

In this study, it is a question of evaluating the effectiveness of the TOVERTAFEL device on the frequent behavioral symptoms in dementia (agitation, ambulation, apathy, anxiety), the quality of life of the patients, as well as on psychotropic treatments.

Eligibility Criteria

Inclusion

Inclusion Criteria:

Man or woman aged 60 to 106.
Patient living in one of the USLD or UHR participating in the project.
Score greater than or equal to 9 for at least one of the following items in theNPI-ES: apathy, agitation, anxiety, depression, aberrant motor behavior.
Presence of TNC according to the standardization and calibration of the MMSE.
The patients recruited must have given themselves, or through a trusted personprovided for in article L. 1111-6 of the Public Health Code, failing this, by thefamily, or, failing that, by a person having close and stable ties with the personconcerned; for adults under guardianship: the guardian or legal representative, foradults under guardianship: the curator, their informed consent to this study whichmust be approved by the Personal Protection Committee (PPC) prior to its completion.

Exclusion

Exclusion Criteria:

Unstable pathology whose nature can interfere with the evaluation variables
Deafness or blindness which could compromise the patient's assessment or hisparticipation in the animation sessions.

Study Design

September 10, 2020

August 31, 2021

Connect with a study center

Hôpital des Charpennes
Villeurbanne, 69100
France
Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.